ABBOTT LABORATORIES $36.59

down -0.24


17/5/2013 07:17 PM  |  NYSE : ABT  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Last Trade: 36.59
Trade Time: May 17 7:24 PM Eastern Daylight Time
Change: -0.24 (-0.65 %)
Prev Close: 36.83
Open: 36.82
Bid: 36.13
Ask: 37.62
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing ABT also viewed: , , , ,

Competitors

Ticker Name Volume % Change
RXPC RADIENT PHARMACEUTICALS 650.4K +1.00%
SPHE SPEARHEAD LIMITED 50.0K +0.50%
RMCP REVOLUTIONS MEDICAL 2.5K +0.46%
KADR ARCADIA RESOURCES 2.1M +0.25%
PCGR PC GROUP 10.0K +0.21%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/3/2013 Warmuth Michael J Executive Vice President -3,960 $37.06 -8.91%
4/1/2013 FREYMAN THOMAS C Executive Vice President -50,917 $35.32 -14.19%
4/1/2013 FREYMAN THOMAS C Executive Vice President 63,800 $22.27 21.63%
3/12/2013 FREYMAN THOMAS C Executive Vice President 16,384 $26.09 5.10%
3/12/2013 FREYMAN THOMAS C Executive Vice President -42,487 $34.93 -12.59%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ABT), click here.
View All

ABT Stock Analysis

  1. Amgen Chased By The Bubble

    (AMGN,PFE,SNY,TEVA,CELG,NVO,MRK,HSP,ABT,AFFY,BIIB,GILD )
    Amgen really needs the pipeline to come through to support this valuation.

  2. It Gets A Little Harder From Here For Covidien

    (COV,JNJ,SYK,BCR,MDT,CSII,ISRG,CNMD,ABT )
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.

  3. Pharma Is Doing All The Pulling For Johnson & Johnson

    (COV,ABT,JNJ,MDT,STJ,ISRG,SYK,RHHBY,ZMH,SNY )
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
Free Reports
  1.

    Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
  2.

    Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
  3.

    Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
Marketplace
Trading Center